Denial of prescription analgesia among people who inject drugs in a Canadian setting

Drug and Alcohol Review

Volumn 34, Issue 2, 2015, Pages 221-228

  Voon, Pauline ^a   Callon, Cody ^a   Nguyen, Paul ^a   Dobrer, Sabina ^a   Montaner, Julio S G ^a,b   Wood, Evan ^a,b   Kerr, Thomas ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diversion; Drug seeking; Methadone; Pain; Prescription opioid

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; CANADA; COHORT ANALYSIS; DIAGNOSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PAIN; PRESCRIPTION DRUG OVERUSE; PROSPECTIVE STUDY; SELF REPORT; SUBSTANCE ABUSE;

ADULT; ANALGESICS, OPIOID; CANADA; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PRESCRIPTION DRUG OVERUSE; PROSPECTIVE STUDIES; SELF REPORT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84924798183     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12226     Document Type: Article

References (46)

1. Morasco BJ, Gritzner S, Lewis L, etal. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain 2011;152:488-497.
2. Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. Lancet 2009;374:1284-1293.
3. Hopper JA, Shafi T. Management of the hospitalized injection drug user. Infect Dis Clin North Am 2002;16:571-587.
4. Pieper B, Templin T. Lower extremity changes, pain, and function in injection drug users. J Subst Abuse Treat 2003;25:91-97.
5. United Nations Office on Drugs and Crime. World Drug Report 2014 (June 2014). Available at: http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf (accessed July 2014).
6. Del Borgo C, Izzi I, Chiarotti F, etal. Multidimensional aspects of pain in HIV-infected individuals. AIDS Patient Care STDS 2001;15:95-102.
7. Martin C, Pehrsson P, Osterberg A, etal. Pain in ambulatory HIV-infected patients with and without intravenous drug use. Eur J Pain 1999;3:157-164.
8. Cousins MJ, Lynch ME. The Declaration Montreal: access to pain management is a fundamental human right. Pain 2011;152:2673-2674.
9. Pieper B, Szczepaniak K, Templin T. Psychosocial adjustment, coping, and quality of life in persons with venous ulcers and a history of intravenous drug use. J Wound Ostomy Continence Nurs 2000;27:227-237.
10. Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. Lancet 2011;377:2226-2235.
11. Baldacchino A, Gilchrist G, Fleming R, Bannister J. Guilty until proven innocent: a qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addict Behav 2010;35:270-272.
12. Breitbart W, Rosenfeld B, Passik S, Kaim M, Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain 1997;72:235-243.
13. Voon P, Callon C, Nguyen P, etal. Self-management of pain among people who inject drugs in Vancouver. Pain Manag 2014;4:27-35.
14. Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005;366:316-318.
15. Obradovic M, Lal A, Liedgens H. Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health Qual Life Outcomes 2013;11:110-118.
16. van der Zanden BP, Dijkgraaf MG, Blanken P, de Borgie CA, van Ree JM, van den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend 2006;82:111-118.
17. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997;36:551-559.
18. NIAAA. Moderate & Binge Drinking. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health. Available at: http://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking (accessed November 2013).
19. SAMHSA. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings). Rockville, MD, 2010.
20. Wood E, Tyndall MW, Spittal PM, etal. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002;16:941-943.
21. Craib KJ, Spittal PM, Wood E, etal. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003;168:19-24.
22. Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs 2006;66:155-174.
23. Tsao JC, Dobalian A, Stein JA. Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. Pain 2005;119:124-132.
24. Fibbi M, Silva K, Johnson K, Langer D, Lankenau SE. Denial of prescription opioids among young adults with histories of opioid misuse. Pain Med 2012;13:1040-1048.
25. Bell K, Salmon A. What women who use drugs have to say about ethical research: findings of an exploratory qualitative study. J Empir Res Hum Res Ethics 2011;6:84-98.
26. Nelson LS, Perrone J. Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). JAMA 2012;308:457-458.
27. Eyler EC. Chronic and acute pain and pain management for patients in methadone maintenance treatment. Am J Addict 2013;22:75-83.
28. Hines S, Theodorou S, Williamson A, Fong D, Curry K. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev 2008;27:519-523.
29. Rowley D, McLean S, O'Gorman A, Ryan K, McQuillan R. Review of cancer pain management in patients receiving maintenance methadone therapy. Am J Hosp Palliat Care 2011;28:183-187.
30. Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain 2005;113:340-346.
31. Pud D, Cohen D, Lawental E, Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 2006;82:218-223.
32. Keane H. Categorising methadone: Addiction and analgesia. Int J Drug Policy 2013;24:e18-24.
33. Devlin RJ, Henry JA. Clinical review: Major consequences of illicit drug consumption. Crit Care 2008;12:202-208.
34. Kaye S, Darke S. Injecting and non-injecting cocaine use in Sydney, Australia: physical and psychological morbidity. Drug Alcohol Rev 2004;23:391-398.
35. Shyu BC, Kiritsy-Roy JA, Morrow TJ, Casey KL. Neurophysiological, pharmacological and behavioral evidence for medial thalamic mediation of cocaine-induced dopaminergic analgesia. Brain Res 1992;572:216-223.
36. Schuelke GS, Terry LC, Powers RH, etal. Cocaine analgesia: an in vivo structure-activity study. Pharmacol Biochem Behav 1996;53:133-140.
37. Pamplona FA, Vendruscolo LF, Takahashi RN. Increased sensitivity to cocaine-induced analgesia in Spontaneously Hypertensive Rats (SHR). Behav Brain Funct 2007;3:9-12.
38. Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev 2005;24:143-155.
39. UK Drug Policy Commission (UKDPC). Sinning and Sinned Against: The Stigmatisation of Problem Drug Users (August 2010). Available at: http://www.ukdpc.org.uk/publications/ (accessed August 2014).
40. Bell K, Salmon A. Pain, physical dependence and pseudoaddiction: redefining addiction for 'nice' people? Int J Drug Policy 2009;20:170-178.
41. McCreaddie M, Lyons I, Watt D, etal. Routines and rituals: a grounded theory of the pain management of drug users in acute care settings. J Clin Nurs 2010;19:2730-2740.
42. Manchikanti L. Prescription drug abuse: what is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources. Pain Physician 2006;9:287-321.
43. Hallinan R, Osborn M, Cohen M, etal. Increasing the benefits and reducing the harms of prescription opioid analgesics. Drug Alcohol Rev 2011;30:315-323.
44. Berg KM, Arnsten JH, Sacajiu G, Karasz A. Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med 2009;24:482-488.
45. Fischer B, Ialomiteanu A, Kurdyak P, etal. Reductions in non-medical prescription opioid use among adults in Ontario, Canada: are recent policy interventions working? Subst Abuse Treat Prev Policy 2013;8:7-10.
46. Stanos SP, Bruckenthal P, Barkin RL. Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clin Proc 2012;87:683-694.